290 Post-Orchidectomy Tumour-Marker Testing in Suspected Testicular Cancer: An Audit Against EAU and BAUS Standards
British Journal of Surgery · 10.07.2026 · 113 (Supplement_6)
DOI: 10.1093/bjs/znag063.211 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Surgery, online erschienen am 10.07.2026. Verfasst von A Elmadani.
Abstract (Originalsprache)
Aim
To evaluate compliance with guideline-recommended timing of post-orchidectomy tumour-marker testing (in 5-7 days) in patients undergoing radical inguinal orchidectomy for suspected testicular germ-cell tumours, and to identify key pathway failures contributing to delayed staging.
Method
A retrospective audit was performed at a single UK district general hospital, examining all adult patients who underwent radical inguinal orchidectomy for suspected testicular cancer over two years (15/11/2023–14/11/2025). Data were collected from electronic patient records, theatre systems, discharge documentation and MDT conclusions. Compliance with preoperative AFP, β-hCG, and LDH measurement and repeat testing within 5–7 days postoperatively was compared against EAU (2025) and BAUS guideline standards. Documentation of a clear post-operative marker plan was also assessed.
Results
23 orchidectomy cases were identified (median age 43 years; 78% malignant germ-cell tumours). All patients had complete pre-operative tumour markers (100% standard achieved). Only 3/23 (13%) had AFP/β-hCG/LDH repeated within the guideline window of 5–7 days post-surgery, against a target of ≥90%. Although 48% eventually had markers checked, these were often delayed by weeks to months and mostly initiated at MDT review. A clear post-operative marker plan was documented in only 26%, indicating this as the key driver of non-compliance. All malignant cases were escalated to MDT review; however, the absence of timely markers risks missing Stage IS disease.
Conclusions
The current pathway delivers excellent pre-operative marker compliance but fails to provide guideline-compliant early post-orchidectomy tumour-marker testing. Introducing automatic post-operative blood test scheduling and pathway education is required to ensure timely staging and oncological safety.
Zitieren
APA
Elmadani, A. (2026). 290 Post-Orchidectomy Tumour-Marker Testing in Suspected Testicular Cancer: An Audit Against EAU and BAUS Standards. British Journal of Surgery, 113(Supplement_6). https://doi.org/10.1093/bjs/znag063.211
Vancouver
Elmadani A. 290 Post-Orchidectomy Tumour-Marker Testing in Suspected Testicular Cancer: An Audit Against EAU and BAUS Standards. British Journal of Surgery. 2026;113(Supplement_6). doi:10.1093/bjs/znag063.211
BibTeX
@article{Elmadani2026,
author = {Elmadani, A},
title = {290 Post-Orchidectomy Tumour-Marker Testing in Suspected Testicular Cancer: An Audit Against EAU and BAUS Standards},
journal = {British Journal of Surgery},
year = {2026},
volume = {113},
number = {Supplement_6},
doi = {10.1093/bjs/znag063.211}
}
EUVIMED